Conference Coverage (ICAAC)
2 New Flu Drugs Fight For Headlines
Published in Gene Therapy Weekly, October 12th, 1998
Two firms are ready to find out, and the potential stakes are enormous. Ten to 20 percent of U.S. residents - 26 to 55 million potential customers - get the flu every year.
The drugs are effective against both influenza A and influenza B, the major circulating virus strains. Both drugs attack the influenza neuraminidase enzyme, essential for the virus to spread from one infected cell to another.
"Neuraminidase inhibitors should provide significant advances in the management of influenza virus infections," concluded Frederick G. Hayden of the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (1998-10-12)
More Articles from Gene Therapy Weekly
- Suicide Gene Therapy (Hepatocellular Carcinoma)
Dual Gene Delivery Enhances Bystander Effect and Cell Killing - Cancer Gene Therapy
Retrovirus-Mediated Transfer of Adenovirus Gene Has In Vivo Antitumor Effect - Combination Therapy
Immunological Factors Combine to Improve Gene Transfer into Marrow Cells - Conference Coverage (ICAAC)
Primary HIV Infection + HAART: Better Than Vaccine? - Transplantation Immunotherapy
Lipid-Mediated IL-10 Gene Transfer Inhibits Graft Rejection - Vascular Gene Therapy
Elastase Pre-Treatment Improves Vascular Gene Transfer - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
